Company profile · Sponsor
s.r.o.
- Pipeline
- 5
- Drugs
- 0
- Patents
- 0
Quick answer
s.r.o. (E2D0F1B) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 0 patents to this profile..
Company facts
Pipeline (5)
Search pipeline →-
Midazolam 1 mg, Psilocybine 5 mg
s.r.o.
Stable Ischemic Heart Disease
1 trial -
A pilot, open label, single dose, randomized, four-period, four-sequence, four-treatment crossover, comparative bioavailability study of UDCA PMCS 500 mg formulation 1 film-coated tablets (test 1 formulation), and UDCA PMCS 500 mg formulation 2 film-coated tablets (test 2 formulation), and UDCA PMCS 500 mg formulation 3 film-coated tablets (test 3 formulation), and reference formulation in healthy, male and female volunteers under fasting conditions.
s.r.o.
UDCA causes a reduction in cholesterol saturation of the bile by inhibiting cholesterol absorption in the intestine and reducing cholesterol secretion into the bile. Presumably, cholesterol gallstones are gradually dissolved by dispersion of the cholesterol and formation of liquid crystals.
1 trial -
A randomized, single dose, cross-over bioavailability study comparing the drug-drug interaction between telmisartan tablets, indapamide tablets, and amlodipine tablets when co-administered versus the administration of each product alone in three arms to healthy volunteers under fasting conditions.
s.r.o.
high blood pressure
1 trial -
A single-dose, randomized, two-period, two-sequence, crossover pilot bioequivalence study on formulations containing rivaroxaban and acetylsalicylic acid in healthy volunteers under fasting conditions.
s.r.o.
increased blood clotting
1 trial -
Safety Assessment of 10-Day Daily Bucco-Oral Administration of Transfer Factor in Healthy Adult Human Subjects
s.r.o.
healthy subjects, It is used in conditions with decreased immunity to enhance it e.g. in case of recurrent and chronic viral infections.
1 trial
Frequently asked questions
What is s.r.o.?
s.r.o. (E2D0F1B) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 0 patents to this profile..
What pipeline programs does s.r.o. sponsor?
We track 5 ClinicalTrials.gov-linked programs for s.r.o., including Midazolam 1 mg, Psilocybine 5 mg and 4 more. Open each program for phase, modality, NCT IDs, and indication details.
Where does s.r.o. company data come from?
Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.